Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cognitive Dysfunction × Methylphenidate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fatigue 5 Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Asthenia 2 Sleep Wake Disorders 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurotoxicity Syndromes 1 Gastrointestinal Neoplasms 1 Depression 1 Cognitive Dysfunction 1 Central Nervous System Neoplasms 1

Interventions

acetaminophen, aspirin, caffeine drug combination 1 Transcranial Direct Current Stimulation 1 Sodium Chloride 1 Methylphenidate 1 G(M1) Ganglioside 1 Electroencephalography 1 Drug Delivery Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02970500 2023-03-23

CogMet

CHU de Quebec-Universite Laval

Phase 2 Terminated

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡